George, evidence-based treatments such as semaglutide and tirzepatide help many patients lose 1521% of their total body weight (when using FDA-approved medications), resulting in meaningful improvements in long-term health
The regulatory T cells, or Tregs, that normally keep the immune system from attacking the body's own tissues either decline in number or lose function
The clinical outcomes data is robust and the benefit-risk profile, in appropriate patient populations, is well established
It is not intended to replace professional medical advice, diagnosis, or treatment
The reduced dose, not the reduced frequency, is what defines microdosing
Temperature and flavor can make a significant difference in your ability to maintain hydration